See also this year's filing and all EDGAR filings for this company.
PDF Report 0000855654_2016_Immunogen_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0000855654, Immunogen Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 292,180,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 16,254,000 |
| 3 | remainder_Assets | 5,389,000 |
| 4 | LiabilitiesCurrent | 35,810,000 |
| 5 | LiabilitiesNoncurrent | 3,997,000 |
| 6 | remainder_Liabilities | 238,912,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 29,924,594 |
| 9 | ResearchAndDevelopmentExpense | 112,912,723 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 140,284,095 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -36,949,776 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 313,823,000 |
| 1 | Liabilities | 278,719,000 |
| 2 | Expenses | 142,837,317 |
| 3 | Revenues | 140,284,095 |
| 4 | StockholdersEquity | 35,104,000 |
| 5 | NetIncome | -2,553,222 |
| 6 | ComprehensiveNetIncome | -21,028,110 |
| 7 | BaseVar | 456,306,594 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.187 |
| 9 | EconomicCapitalRatio | 1.59 |
Edgar->Model Mapping
Feature Distribution
Change over Time
